Wednesday, September 28, 2022 9:19:37 PM
On September 23, 2022, we entered into a Securities Purchase Agreement and issued and sold to an institutional investor, a Promissory Note in the principal sum of
$700,000.00, which amount is the $644,000 actual amount of the purchase price plus an original issue discount in the amount of $56,000. In connection with the issuance of the note, we issued to the investor warrants to purchase 2,800,000 shares of our common stock at an exercise price of $0.225, as well as returnable warrants to purchase 7,000,000 shares of our common stock at an exercise price of $0.30, in each case subject to adjustment. As a result of the transaction, our existing lenders triggered their “most favored nation” clause which resulted in their existing notes receiving some of the same terms and conditions we granted to the new investor’s notes and warrants.
The proceeds from the sale of the note and warrants is expected to be used for business development, working capital, operations and required debt service.
Recent NGTF News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/15/2024 09:15:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 09:21:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 09:44:09 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/31/2024 09:15:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 09:15:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 02:00:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 10:19:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/29/2023 08:30:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 10:18:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 09:15:21 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 09:30:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 08:40:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 04:45:17 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:10:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 08:15:11 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/29/2023 08:15:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/21/2023 06:07:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2023 01:39:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2023 12:20:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:15:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/07/2023 08:15:36 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM